autologous blood monocyte vesicles

Autologous blood monocyte vesicles are a type of extracellular vesicle (EV) derived specifically from a patient's own (autologous) circulating blood monocytes. These membrane-bound particles, which include exosomes and larger microvesicles, are secreted by activated or stressed cells and play key roles in intercellular communication. Monocyte-derived EVs can carry proteins, lipids, mRNAs, and microRNAs that modulate immune responses and other physiological processes. When used therapeutically or experimentally, these autologous EVs may minimize immunogenicity compared to allogeneic sources. Research has explored their immunoregulatory effects—such as influencing T cell activation—and their potential as biomarkers or therapeutic agents in cancer immunotherapy and autoimmune diseases[2][6][10]. Clinical trials have demonstrated the feasibility and safety of using autologous dendritic cell- or monocyte-derived EVs for cancer therapy[6], but specific clinical development for pure "monocyte" vesicle products remains limited.

Other names

autologous blood monocyte extracellular vesiclesautologous monocyte-derived extracellular vesiclesautologous EVs from blood monocytes